交易 Jazz Pharmaceuticals plc - JAZZ CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
价差 | 1.07 | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.025457% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | 0.003235% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Jazz Pharmaceuticals PLC ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平仓 | Change | Change (%) | 開倉 | High | Low |
---|---|---|---|---|---|---|
Jun 2, 2023 | 127.79 | -0.16 | -0.13% | 127.95 | 130.21 | 127.35 |
Jun 1, 2023 | 128.50 | 1.59 | 1.25% | 126.91 | 129.06 | 125.39 |
May 31, 2023 | 128.14 | 2.33 | 1.85% | 125.81 | 129.74 | 125.40 |
May 30, 2023 | 126.37 | 1.31 | 1.05% | 125.06 | 127.34 | 124.96 |
May 26, 2023 | 125.65 | -0.29 | -0.23% | 125.94 | 127.39 | 125.14 |
May 25, 2023 | 127.07 | 0.37 | 0.29% | 126.70 | 127.76 | 125.09 |
May 24, 2023 | 128.72 | -0.01 | -0.01% | 128.73 | 130.55 | 128.00 |
May 23, 2023 | 129.79 | -2.14 | -1.62% | 131.93 | 133.66 | 129.67 |
May 22, 2023 | 132.67 | -0.98 | -0.73% | 133.65 | 135.07 | 132.05 |
May 19, 2023 | 133.80 | 2.49 | 1.90% | 131.31 | 134.79 | 131.31 |
May 18, 2023 | 131.61 | 1.93 | 1.49% | 129.68 | 131.85 | 129.26 |
May 17, 2023 | 131.54 | 1.66 | 1.28% | 129.88 | 132.16 | 129.30 |
May 16, 2023 | 130.93 | -2.76 | -2.06% | 133.69 | 133.69 | 130.22 |
May 15, 2023 | 134.13 | 0.46 | 0.34% | 133.67 | 136.39 | 133.43 |
May 12, 2023 | 135.15 | -1.25 | -0.92% | 136.40 | 137.26 | 133.46 |
May 11, 2023 | 136.57 | 0.14 | 0.10% | 136.43 | 140.47 | 135.79 |
May 10, 2023 | 136.08 | 1.35 | 1.00% | 134.73 | 137.38 | 133.40 |
May 9, 2023 | 134.82 | -1.99 | -1.45% | 136.81 | 137.59 | 134.70 |
May 8, 2023 | 138.03 | -1.03 | -0.74% | 139.06 | 139.85 | 136.82 |
May 5, 2023 | 138.84 | 2.14 | 1.57% | 136.70 | 139.67 | 136.60 |
Jazz Pharmaceuticals plc Events
时间(协调世界时) (UTC) | 国家/地区 | 事件 |
---|---|---|
Tuesday, June 13, 2023 | ||
时间(协调世界时) (UTC) 22:20 | 国家/地区 IE
| 事件 Jazz Pharmaceuticals PLC at Goldman Sachs Healthcare Conference Jazz Pharmaceuticals PLC at Goldman Sachs Healthcare ConferenceForecast -Previous - |
Friday, July 28, 2023 | ||
时间(协调世界时) (UTC) 08:45 | 国家/地区 IE
| 事件 Jazz Pharmaceuticals PLC Annual Shareholders Meeting Jazz Pharmaceuticals PLC Annual Shareholders MeetingForecast -Previous - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
总收入 | 3659.37 | 3094.24 | 2363.57 | 2161.76 | 1890.92 |
收入 | 3659.37 | 3094.24 | 2363.57 | 2161.76 | 1890.92 |
收入成本,共计 | 540.517 | 440.76 | 148.917 | 127.93 | 121.544 |
毛利 | 3118.86 | 2653.48 | 2214.65 | 2033.83 | 1769.38 |
总营业费用 | 3724.9 | 2923.96 | 1990.59 | 1629.39 | 1277.51 |
销售/一般/行政费用,总计 | 1376.17 | 1222.68 | 854.233 | 736.942 | 683.53 |
研究与开发 | 1034.6 | 505.748 | 586.625 | 409.701 | 226.616 |
Depreciation / Amortization | 599.169 | 525.769 | 259.58 | 354.814 | 201.498 |
异常费用(收入) | 174.448 | 229 | 141.239 | 0 | 44.321 |
营业收入 | -65.528 | 170.278 | 372.973 | 532.374 | 613.413 |
利息收入(费用),非经营净值 | -307.256 | -283.116 | -97.878 | -78.072 | -86.153 |
税前净收入 | -372.784 | -112.838 | 275.095 | 454.302 | 527.26 |
税后净收入 | -214.139 | -328.954 | 241.578 | 527.456 | 447.091 |
少数股东权益 | |||||
未计算非常项目前的净收益 | -224.06 | -329.668 | 238.616 | 523.367 | 447.091 |
净收入 | -224.06 | -329.668 | 238.616 | 523.367 | 447.098 |
普通股股东可获收益 (不含非经常性项目) | -224.06 | -329.668 | 238.616 | 523.367 | 447.091 |
普通股股东可获收益 (含非經常性項目) | -224.06 | -329.668 | 238.616 | 523.367 | 447.098 |
摊薄调整 | 0 | ||||
摊薄净收入 | -224.06 | -329.668 | 238.616 | 523.367 | 447.098 |
摊薄后加权平均股 | 62.539 | 59.694 | 56.517 | 57.55 | 61.221 |
扣除特别项目的每股摊薄盈利 | -3.58272 | -5.52263 | 4.22202 | 9.09413 | 7.30289 |
每股正常摊薄盈利 | -1.7696 | -3.02908 | 6.4166 | 9.09413 | 7.91677 |
非常规项目总计 | 0 | 0.0075 | |||
Equity In Affiliates | -9.921 | -0.714 | -2.962 | -4.089 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
总收入 | 892.812 | 972.123 | 940.652 | 932.878 | 813.721 |
收入 | 892.812 | 972.123 | 940.652 | 932.878 | 813.721 |
收入成本,共计 | 128.644 | 167.364 | 133.661 | 124.208 | 115.284 |
毛利 | 764.168 | 804.759 | 806.991 | 808.67 | 698.437 |
总营业费用 | 766.757 | 1235.51 | 915.889 | 847.332 | 726.172 |
销售/一般/行政费用,总计 | 297.917 | 383.203 | 317.678 | 325.673 | 308.813 |
研究与开发 | 190.41 | 547.555 | 148.87 | 208.195 | 129.981 |
Depreciation / Amortization | 149.786 | 137.387 | 141.232 | 148.456 | 172.094 |
异常费用(收入) | 0 | 174.448 | 40.8 | ||
营业收入 | 126.055 | -263.386 | 24.763 | 85.546 | 87.549 |
利息收入(费用),非经营净值 | -70.954 | -76.607 | -84.893 | -64.532 | -81.224 |
税前净收入 | 55.101 | -339.993 | -60.13 | 21.014 | 6.325 |
税后净收入 | 70.425 | -239.951 | -17.103 | 37.126 | 5.789 |
Equity In Affiliates | -1.005 | -0.773 | -2.545 | -2.461 | -4.142 |
未计算非常项目前的净收益 | 69.42 | -240.724 | -19.648 | 34.665 | 1.647 |
净收入 | 69.42 | -240.724 | -19.648 | 34.665 | 1.647 |
普通股股东可获收益 (不含非经常性项目) | 69.42 | -240.724 | -19.648 | 34.665 | 1.647 |
普通股股东可获收益 (含非經常性項目) | 69.42 | -240.724 | -19.648 | 34.665 | 1.647 |
摊薄净收入 | 69.42 | -240.724 | -19.648 | 34.665 | 1.647 |
摊薄后加权平均股 | 73.771 | 63.061 | 62.785 | 63.431 | 62.907 |
扣除特别项目的每股摊薄盈利 | 0.94102 | -3.81732 | -0.31294 | 0.5465 | 0.02618 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常摊薄盈利 | 0.94102 | -3.81732 | 1.49308 | 0.96459 | 0.02618 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流动资产总额 | 2606.14 | 2611.33 | 2839.57 | 1630.27 | 1234.01 |
现金和短期投资 | 881.482 | 591.448 | 2132.77 | 1077.34 | 824.622 |
现金等价物 | 517.464 | ||||
短期投资 | 30 | 80.701 | 1615.65 | 744.172 | 609.016 |
应收账款总额,净额 | 742.628 | 563.36 | 396.49 | 355.987 | 263.838 |
Accounts Receivable - Trade, Net | 651.493 | 563.36 | 396.49 | 355.987 | 263.838 |
Total Inventory | 714.061 | 1072.72 | 95.396 | 78.608 | 52.956 |
Prepaid Expenses | 91.912 | 131.413 | 62.422 | 39.434 | 25.017 |
Other Current Assets, Total | 176.057 | 252.392 | 152.491 | 78.895 | 67.572 |
Total Assets | 10835.3 | 12298.6 | 6535.9 | 5538.9 | 5203.49 |
Property/Plant/Equipment, Total - Net | 301.376 | 343.423 | 257.104 | 270.891 | 200.358 |
Property/Plant/Equipment, Total - Gross | 409.023 | 428.794 | 324.692 | 326.148 | 249.966 |
Accumulated Depreciation, Total | -107.647 | -85.371 | -67.588 | -55.257 | -49.608 |
Goodwill, Net | 1692.66 | 1827.61 | 958.303 | 920.018 | 927.63 |
Intangibles, Net | 5794.44 | 7152.33 | 2195.05 | 2440.98 | 2731.33 |
Other Long Term Assets, Total | 440.64 | 363.945 | 285.875 | 276.743 | 110.164 |
Total Current Liabilities | 933.193 | 809.303 | 653.745 | 364.49 | 345.487 |
Accounts Payable | 90.758 | 100.298 | 26.945 | 47.545 | 40.602 |
Accrued Expenses | 802.874 | 647.479 | 349.107 | 266.836 | 263.427 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 31.381 | 31.406 | 246.322 | 33.387 | 33.387 |
Other Current Liabilities, Total | 8.18 | 30.12 | 31.371 | 16.722 | 8.071 |
Total Liabilities | 7749.52 | 8333.45 | 2876.16 | 2427.92 | 2446.07 |
Total Long Term Debt | 5698.55 | 6025.21 | 1848.52 | 1573.87 | 1563.03 |
Long Term Debt | 5693.34 | 6018.94 | 1848.52 | 1573.87 | 1563.03 |
Deferred Income Tax | 944.337 | 1300.54 | 130.397 | 224.095 | 309.097 |
Other Liabilities, Total | 173.44 | 198.392 | 243.498 | 265.461 | 228.46 |
Total Equity | 3085.73 | 3965.19 | 3659.75 | 3110.98 | 2757.42 |
Common Stock | 0.061 | 0.061 | 0.061 | 0.061 | 0.061 |
Additional Paid-In Capital | 3477.12 | 3534.79 | 2633.67 | 2266.03 | 2113.63 |
Retained Earnings (Accumulated Deficit) | 734.058 | 830.698 | 1160.37 | 1068.29 | 841.522 |
Other Equity, Total | -1125.51 | -400.36 | -134.352 | -223.393 | -197.791 |
Total Liabilities & Shareholders’ Equity | 10835.3 | 12298.6 | 6535.9 | 5538.9 | 5203.49 |
Total Common Shares Outstanding | 63.214 | 61.633 | 56.171 | 56.14 | 57.504 |
Cash | 334.018 | 510.747 | 517.117 | 333.172 | 215.606 |
Capital Lease Obligations | 5.21 | 6.269 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
流动资产总额 | 2784.65 | 2606.14 | 2571.5 | 2590.83 | 2500.86 |
现金和短期投资 | 1167.91 | 881.482 | 899.358 | 771.265 | 490.835 |
Cash | 424.139 | 334.018 | 296.686 | 380.328 | 410.125 |
现金等价物 | 563.772 | 517.464 | 542.672 | 290.937 | |
短期投资 | 180 | 30 | 60 | 100 | 80.71 |
应收账款总额,净额 | 681.154 | 651.493 | 601.179 | 594.034 | 572.392 |
Accounts Receivable - Trade, Net | 623.938 | 651.493 | 601.179 | 594.034 | 572.392 |
Total Inventory | 674.778 | 714.061 | 728.074 | 861.705 | 985.454 |
Prepaid Expenses | 72.779 | 91.912 | 92.877 | 108.304 | 117.399 |
Other Current Assets, Total | 188.028 | 267.192 | 250.016 | 255.525 | 334.776 |
Total Assets | 11047.1 | 10835.3 | 10384.7 | 11200.1 | 11768.9 |
Property/Plant/Equipment, Total - Net | 303.09 | 301.376 | 290.067 | 317.888 | 341.044 |
Property/Plant/Equipment, Total - Gross | 419.23 | 409.023 | 388.038 | 414.57 | 433.74 |
Accumulated Depreciation, Total | -116.14 | -107.647 | -97.971 | -96.682 | -92.696 |
Goodwill, Net | 1723.44 | 1692.66 | 1592.64 | 1687.65 | 1782.44 |
Intangibles, Net | 5764.21 | 5794.44 | 5570.39 | 6237.96 | 6783.06 |
Other Long Term Assets, Total | 471.732 | 440.64 | 360.067 | 365.805 | 361.516 |
Total Current Liabilities | 908.902 | 933.193 | 812.954 | 705.442 | 737.409 |
Accounts Payable | 125.454 | 90.758 | 102.249 | 74.161 | 73.336 |
Accrued Expenses | 711.779 | 803.255 | 630.648 | 569.174 | 596.292 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 31 | 31 | 31 | 31 | 31 |
Other Current Liabilities, Total | 40.669 | 8.18 | 49.057 | 31.107 | 36.781 |
Total Liabilities | 7712.08 | 7749.52 | 7639.47 | 7999.35 | 8160.43 |
Total Long Term Debt | 5689.66 | 5693.34 | 5695.81 | 5990 | 5992.87 |
Long Term Debt | 5689.66 | 5693.34 | 5695.81 | 5990 | 5992.87 |
Deferred Income Tax | 932.247 | 944.337 | 933.67 | 1096.42 | 1222.08 |
Other Liabilities, Total | 181.273 | 178.65 | 197.035 | 207.496 | 208.069 |
Total Equity | 3335.04 | 3085.73 | 2745.19 | 3200.78 | 3608.49 |
Common Stock | 0.061 | 0.061 | 0.061 | 0.061 | 0.061 |
Additional Paid-In Capital | 3511.73 | 3477.12 | 3388 | 3312.32 | 3239.33 |
Retained Earnings (Accumulated Deficit) | 803.478 | 734.058 | 974.782 | 994.43 | 959.819 |
Other Equity, Total | -980.23 | -1125.51 | -1617.65 | -1106.03 | -590.72 |
Total Liabilities & Shareholders’ Equity | 11047.1 | 10835.3 | 10384.7 | 11200.1 | 11768.9 |
Total Common Shares Outstanding | 63.987 | 63.214 | 62.89 | 62.623 | 62.244 |
Capital Lease Obligations |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | -224.06 | -329.668 | 238.616 | 523.367 | 447.098 |
经营活动产生的现金 | 1271.98 | 778.507 | 899.648 | 776.401 | 798.904 |
经营活动产生的现金 | 30.302 | 26.714 | 18.673 | 15.342 | 15.233 |
Amortization | 599.169 | 525.769 | 259.58 | 354.814 | 201.498 |
Deferred Taxes | -292.251 | 69.198 | -136.937 | -236.61 | -88.815 |
非现金物品 | 875.52 | 311.361 | 605.153 | 269.572 | 200.604 |
Cash Taxes Paid | 94.681 | 271.217 | 226.823 | 183.61 | 164.217 |
已付现金利息 | 270.671 | 138.271 | 42.47 | 43.002 | 42.706 |
营运资金的变化 | 283.297 | 175.133 | -85.437 | -150.084 | 23.286 |
投资活动产生的现金 | -446.23 | -5212.14 | -1007.67 | -155.3 | -394.487 |
资本支出 | -498.194 | -45.532 | -379.254 | -182.335 | -131.47 |
其他投资现金流量项目,总计 | 51.964 | -5166.61 | -628.416 | 27.035 | -263.017 |
融资活动产生的现金 | -529.491 | 3970.52 | 528.073 | -293.745 | -479.13 |
融资现金流项目 | -45.443 | -35.602 | -16.877 | -16.739 | -23.078 |
股票的发行(报废),净额 | 97.966 | 135.261 | -46.856 | -243.619 | -430.335 |
债务的发行(退还),净额 | -582.014 | 3870.86 | 591.806 | -33.387 | -25.717 |
外汇效应 | -6.222 | -3.207 | 0.374 | 0.366 | -1.7 |
现金净变化 | 290.034 | -466.321 | 420.425 | 327.722 | -76.413 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 69.42 | -224.06 | 16.664 | 36.312 | 1.647 |
Cash From Operating Activities | 320.708 | 1271.98 | 930.006 | 512.015 | 208.979 |
Cash From Operating Activities | 7.574 | 30.302 | 22.958 | 15.364 | 7.617 |
Amortization | 149.786 | 599.169 | 461.782 | 320.55 | 172.094 |
Deferred Taxes | -66.061 | -292.251 | -146.874 | -82.315 | -45.339 |
Non-Cash Items | 81.207 | 875.52 | 421.208 | 208.514 | 49.707 |
Changes in Working Capital | 78.782 | 283.297 | 154.268 | 13.59 | 23.253 |
Cash From Investing Activities | -4.822 | -446.23 | -121.852 | -126.454 | -37.292 |
Capital Expenditures | -4.822 | -498.194 | -113.816 | -118.718 | -37.292 |
Other Investing Cash Flow Items, Total | 51.964 | -8.036 | -7.736 | 0 | |
Cash From Financing Activities | -29.788 | -529.491 | -549.087 | -260.034 | -270.811 |
Financing Cash Flow Items | -43.266 | -45.443 | -42.632 | -40.065 | -33.776 |
Issuance (Retirement) of Stock, Net | 21.228 | 97.966 | 67.809 | 46.549 | 21.729 |
Issuance (Retirement) of Debt, Net | -7.75 | -582.014 | -574.264 | -266.518 | -258.764 |
Foreign Exchange Effects | 0.331 | -6.222 | -11.157 | -5.71 | -1.489 |
Net Change in Cash | 286.429 | 290.034 | 247.91 | 119.817 | -100.613 |
Cash Taxes Paid | 94.681 | ||||
Cash Interest Paid | 270.671 |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.597 | 6142541 | 124439 | 2023-03-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 8.3875 | 5368413 | -14950 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 3.6399 | 2329692 | 24635 | 2023-03-31 | LOW |
LSV Asset Management | Investment Advisor | 3.6222 | 2318403 | 262509 | 2023-03-31 | LOW |
JP Morgan Asset Management | Investment Advisor | 2.9841 | 1909975 | -517529 | 2023-03-31 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 2.8997 | 1855940 | -61950 | 2023-03-31 | LOW |
Polaris Capital Management, LLC | Investment Advisor | 2.0434 | 1307860 | 54500 | 2023-03-31 | LOW |
Franklin Advisers, Inc. | Investment Advisor/Hedge Fund | 2.0082 | 1285362 | 12863 | 2023-03-31 | LOW |
Renaissance Technologies LLC | Hedge Fund | 1.9602 | 1254609 | -35406 | 2023-03-31 | HIGH |
Deep Track Capital LP | Hedge Fund | 1.8749 | 1200000 | 326447 | 2023-03-31 | HIGH |
Millennium Management LLC | Hedge Fund | 1.868 | 1195581 | 719435 | 2023-03-31 | HIGH |
Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 1.8257 | 1168505 | 358107 | 2023-03-31 | LOW |
Mulligan (Seamus C) | Individual Investor | 1.8159 | 1162239 | 4185 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.4902 | 953781 | 17166 | 2023-03-31 | LOW |
Swedbank Robur Fonder AB | Investment Advisor/Hedge Fund | 1.4795 | 946960 | 0 | 2023-04-30 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 1.4197 | 908653 | -196782 | 2023-03-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 1.3124 | 840003 | 2441 | 2023-03-31 | LOW |
Samlyn Capital, LLC | Hedge Fund | 1.2321 | 788625 | 166789 | 2023-03-31 | HIGH |
Janus Henderson Investors | Investment Advisor/Hedge Fund | 1.0671 | 682973 | -413870 | 2023-03-31 | LOW |
Avidity Partners Management LP | Hedge Fund | 1.0591 | 677900 | -49641 | 2023-03-31 | LOW |
交易计算器
如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Jazz Pharma Company profile
关于 Jazz Pharmaceuticals plc
爵士药业公共有限公司是一家生物制药公司。 该公司专注于开发和商业化产品,以满足未满足的医疗需求。 公司拥有多样化的产品和候选产品组合,重点在睡眠和血液/肿瘤领域。 公司的主要上市产品包括Xyrem(羟苯磺酸钠口服溶液),用于治疗嗜睡症患者的痉挛和白天过度嗜睡;Erwinaze用于治疗急性淋巴细胞白血病(ALL),以及Defitelio(去纤化)用于治疗严重的肝静脉闭塞症(VOD)。 公司还将Prialt商业化,这是一种鞘内注射的齐康诺肽,经美国食品和药物管理局批准,用于管理需要鞘内治疗的严重慢性疼痛患者,以及对其他治疗(如全身镇痛药、辅助治疗或鞘内吗啡)不耐受或难治的患者。
Industry: | Pharmaceuticals (NEC) |
Fifth Fl
Waterloo Exchange
DUBLIN
DUBLIN 4
IE
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球535,000万多名交易者的一份子,选择利用Capital.com进行交易吧。